September 06, 2011 07:30 ET

Smart Holdings Aims to Capture the 50 Million Uninsured Americans

Note to Editor, the Following Is an Investment Opinion Issued by the IO NewsWire

NEW YORK, NY--(Marketwire - Sep 6, 2011) - Smart Holdings, Inc. (PINKSHEETS: SMHS) has launched a proprietary search engine for the public to use in the comparison of both local and mail order FDA approved pharmaceuticals.

Unlike other search engines that provide similar services, Smart Holdings requires users to have a prescription. Smart Holdings other unique feature is that they do not have a cap or approval process, customers with or without a prescription drug plan can benefit from cost savings over a visit to their local pharmacy.

To find out more, please visit

Other active stocks are Walgreens (NYSE: WAG) Express Scripts (NASDAQ: ESRX) and Medco Health Solutions (NYSE: MHS).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information